Skip to main content

Table 3 Unreasonable medication omission over 12 months

From: Implementation of clinical audit to improve adherence to guideline-recommended therapy in acute coronary syndrome

Drugs Unjustifiable reason for omission of drugs N
DAPT Medication omission error by prescriber 2
ACEI Borderline blood pressure level 15
Borderline potassium level 7
Medication omission error by prescriber 11
Transcribing error in discharge prescription 8
Borderline serum creatinine level 6
Contrast-induced nephropathy during hospital admission 13
Beta-blockers Medication omission error by prescriber 19
Non-revascularized RCA 14
Fear of worsening lung function in patients with COPD 7
Apprehensive to initiate beta-blocker and plan to introduce at follow-up 22
  1. DAPT dual antiplatelet therapy, ACEI angiotensin-converting enzyme inhibitor, RCA right coronary artery, COPD chronic obstructive pulmonary disease